-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YH-003 in Pancreatic Ductal Adenocarcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.YH-003 in Pancreatic Ductal AdenocarcinomaDrug Details:YH-003 is under development for the treatment of solid tumors including...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PMKS-005
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PMKS-005 Drug Details PMKS-005 (PMK-N01GI2)is under development for the treatment of peptic ulcer, acute...
-
Product Insights
Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peptic Ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PMKM-02GI1
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PMKM-02GI1 Drug Details PMKM-02GI1 is under development for the treatment of alcoholic fatty liver...